Although no threshold has been established for protective immunity, antibody levels in vaccinated solid organ transplant recipients were well below that which has been observed in immunocompetent patients.
Lupus nephritis recurrences, while rare, typically happen within a few years of kidney transplantation.
Investigators recommended close surveillance after COVID-19 vaccination of kidney transplant recipients and suggested the possibility that a third dose may be required in less responsive patients.
In adjusted analyses, related donor-recipient pairs had a significant 5% increased risk for allograft failure compared with unrelated donor-recipient pairs.
Interventions may be needed to achieve gender and racial equity in access to kidney transplantation across end-stage renal disease networks in the United States.
Investigators also confirmed racial disparities in COVID-19 hospitalizations and overall deaths early in the pandemic among patients with ESKD.
Investigators report encouraging results from a small observational study testing the effect of preemptive therapeutic plasma exchange and rituximab in kidney transplant recipients whose primary cause of kidney failure was focal segmental glomerulosclerosis.
Each 1 mEq/L increase in serum bicarbonate in kidney transplant recipients is associated with a 10% reduction in graft failure risk, a study found.
Ratio of IL-10/TNFα produced by T1B 3 months after renal transplantation predicts clinical, subclinical rejection during first year.
Kidney transplant candidates aged 65 years or older significantly improved their survival by receiving a standard rather than an expanded criteria donor kidney or continuing on dialysis, a Belgian study showed.